Anifrolumab Treatment is Associated With DORIS-0 Remission in Adults With Systemic Lupus Erythematosus: Real-World Outcomes From an Academic Lupus Registry (ACR Convergence 2026) - Sep 8, 2026 - Abstract #1246; Pres time: Nov 9, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Real-world • Real-world evidence • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|